Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Consolidated Net Income (2018 - 2025)

Dna X (SONM) has disclosed Consolidated Net Income for 8 consecutive years, with -$4.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Consolidated Net Income fell 89.21% year-over-year to -$4.8 million, compared with a TTM value of -$34.0 million through Sep 2025, down 154.2%, and an annual FY2024 reading of -$34.3 million, down 38004.44% over the prior year.
  • Consolidated Net Income was -$4.8 million for Q3 2025 at Dna X, up from -$7.5 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $12.8 million in Q4 2022 and bottomed at -$22.3 million in Q4 2024.
  • Average Consolidated Net Income over 5 years is -$4.5 million, with a median of -$4.2 million recorded in 2022.
  • The sharpest move saw Consolidated Net Income surged 209.39% in 2022, then plummeted 1545.23% in 2024.
  • Year by year, Consolidated Net Income stood at -$11.7 million in 2021, then soared by 209.39% to $12.8 million in 2022, then plummeted by 110.53% to -$1.4 million in 2023, then tumbled by 1545.23% to -$22.3 million in 2024, then surged by 78.65% to -$4.8 million in 2025.
  • Business Quant data shows Consolidated Net Income for SONM at -$4.8 million in Q3 2025, -$7.5 million in Q2 2025, and $458000.0 in Q1 2025.